➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
Merck
AstraZeneca
Baxter

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Patent: 6,624,297

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,624,297
Title: Compositions for the genetic modification of plants
Abstract:Methods and compositions for the targeted integration of nucleotide sequences into a plant are provided. Particularly, the present invention is drawn to compositions comprising polynucleotide sequences having the following operably linked components: an intron, a nucleotide sequence of interest, and a terminator region, wherein the polynucleotide sequence comprises one or more recombination sites. The recombination sites are non-identical to one another and one of the recombination sites is contained within the intron.
Inventor(s): Baszczynski; Christopher L. (Urbandale, IA), Bowen; Benjamin A. (Des Moines, IA), Peterson; David J. (Ames, IA), Tagliani; Laura A. (Ankeny, IA)
Assignee: Pioneer Hi-Bred International, Inc. (Des Moines, IA)
Application Number:09/455,050
Patent Claims:see list of patent claims

Details for Patent 6,624,297

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Pioneer Hi-Bred International, Inc. (Des Moines, IA) 2017-11-18 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Pioneer Hi-Bred International, Inc. (Des Moines, IA) 2017-11-18 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Pioneer Hi-Bred International, Inc. (Des Moines, IA) 2017-11-18 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
AstraZeneca
McKinsey
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.